All Professionals
Overview
Jeff Hartlin is a partner and chair of the Corporate Department of Paul Hastings in Palo Alto and is based in the firm’s Palo Alto and San Diego offices. Jeff concentrates his practice in corporate law, capital-raising, mergers & acquisitions and securities and has represented public and private companies in the software, hardware, information technology, biotechnology/biopharmaceutical, medical device, Web 3.0, semiconductor, clean technology and financial industries. His experience in all aspects of the capital raising process includes representing issuers, underwriters, venture capital firms and placement agents in IPOs, SPAC financings, registered directs, at-the-market offerings and rights offerings, as well as venture and angel-backed private placements, PIPEs, debt financings, Rule 144A transactions, reverse mergers and Regulation S offerings.
Jeff also routinely represents startup and other early-stage companies from incorporation through early financing, pre-IPO capital raising, IPO and eventual sale. Jeff has represented several public and private companies in equity and debt private placements with a combined value of several billion. He also represents Nasdaq and NYSE companies with their periodic reporting requirements and listing qualification issues. He regularly advises boards of directors and management of public and private companies regarding corporate governance issues, including the Sarbanes-Oxley Act, the Dodd-Frank Act and the JOBS Act. Jeff also represents public and private corporations in merger and acquisition transactions, de-SPAC transactions, joint ventures, leveraged and non-leveraged acquisitions, spinoffs, spin-ins and dispositions. He is frequently engaged to advise companies in activist stockholder matters.
Accolades
- Chambers USA named Mr. Hartlin to multiple of its lists of leading lawyers in California capital markets transactions
- The Legal 500, M&A: Large Deals $1Bn+ (2023)
- The Legal 500, Capital Markets: Equity: Equity Offerings - Advice to Issuers (2021)
- Selected for inclusion in multiple editions of San Diego Super Lawyers
- Selected for inclusion in multiple editions of Southern California Super Lawyers
- Named a winner of the M&A Advisor 2012 (West) '40 Under 40' Award, which recognizes the emerging leaders of the M&A, financing, and turnaround industries
Education
- University of Virginia School of Law, J.D. (Editor-in-Chief of the Virginia Tax Review)
- University of California Davis, B.A. (Phi Beta Kappa); NCAA Men's Varsity Soccer and Track & Field
Representations
- Captiv8 in its sale to Publicis Groupe
- Aardvark Therapeutics, Inc. in its initial public offering
- Grid Aero, Inc. in its preferred stock financing
- Toolkit, Inc. in its preferred stock financing
- Pallas Security, Inc. in its preferred stock financing
- Sandbox, Inc. preferred stock financing
- Ellis Technologies, Inc. in its preferred stock financings
- Hummingbird Regtech in its acquisition of LogicLoop
- Xencor, Inc. in its underwritten public offering
- Vantage Discovery, Inc. in its preferred stock financing
- Kyverna Therapeutics, Inc. in its initial public offering
- Zededa, Inc. in its preferred stock financings
- Jasper Therapeutics, Inc. in its reverse merger (deSPAC) and financing transactions
- Uplift, Inc. in its sale to Upgrade, Inc.
- Polychain Capital in its investment in Uniswap Labs
- Perennial Labs in its financing transactions
- Corcept Therapeutics Incorporated in its self-tender offer
- Swimlane, Inc. in its Series C preferred stock financing
- Scilex Holding Company in its reverse merger (deSPAC) with Vickers Vantage Corp. I
- PSL Holdings, Inc. in its equity financing
- Auradine, Inc. in its Series A preferred stock financing
- Masimo Corporation in its IPO and acquisitions of Sound United, the Connected Care business of NantHealth, Spire Semiconductor and PhaseIn AB
- Millicast in its sale to Dolby
- Indapta Therapeutics, Inc. in its preferred stock financing led by Vertex and RA Capital
- Orma Health, Inc. in its sale to Apollo Medical
- Mir Protocol in its sale to Polygon
- CareDx, Inc. in its financings, option exchange program and acquisitions of MedActionPlan, TransChart, XynManagement, Inc. and OTTR
- Ava Labs, Inc. (Avalanche) in its corporate matters
- NeuBase Therapeutics, Inc. in its reverse merger with Ohr Pharmaceutical and acquisition of assets of Vera Therapeutics
- FuzzyBot, Inc. in its preferred stock financing
- Alpha Teknova, Inc. in its initial public offering
- Penumbra Labs, Inc. in its preferred stock financing
- Hero Research, Inc. in its sale to People.ai
- Jasper Therapeutics, Inc. in its reverse merger (deSPAC) with Amplitude Healthcare Acquisition Corporation
- Seqster PDM in its preferred stock financing
- River Financial in its corporate matters and preferred stock financings
- Paige.ai, Inc. in its preferred stock financing
- Orphion Therapeutics, Inc. in its preferred stock financing
- Aterian, Inc. in its IPO and acquisitions of Truweo and various e-commerce business brands
- Valente Sherman, Inc. (VISO Trust) in its preferred stock financings
- Zycada Networks, Inc. in its preferred stock financing
- Kasha Global Inc. in its preferred stock financing
- kimkim, Inc. in its financing transaction
- Polychain Capital in its investments
- Veriflow Systems, Inc. in its financings and sale to VMware, Inc.
- PredictImmune Ltd. in its preferred stock financing
- Scilex Holding Company in its financings and acquisition of Semnur Pharmaceuticals, Inc.
- selectION, Inc. in its preferred stock financing
- Aardvark Therapeutics, Inc. in its preferred stock financings
- OneStream Software LLC in its financing by KKR
- Zededa, Inc. in its preferred stock financings
- Oasis Labs in its financings and corporate matters
- Seelos Therapeutics, Inc. in its reverse merger with Apricus Biosciences, Inc., license with Ligand Pharmaceuticals and financings
- BlastWave, Inc. in its preferred stock financing
- Hummingbird Regtech, Inc. in its preferred stock financings
- healthblock, Inc. in its financing led by XSeed Capital
- Integrated DNA Technologies, Inc. in its financing led by Summit Partners, partnership with Illumina and sale to Danaher Corporation
- Shift Financial, Inc. in its merger with Ledge, Inc.
- Mobile Gaming Technologies in its partnership with Arsenal Football Club
- Redmile Group, LLC in its financings
- Corsair Components in its sale to EagleTree Capital
- Darmiyan, Inc. in its financing transactions
- Mission Bio, Inc. in its venture-backed financing transactions
- Tapclicks, Inc. in its debt financing by SaaS Capital
- J.T. Posey Company in its sale to RoundTable Healthcare Partners
- Biopop in its sale to Intrexon Corporation
- Enplas America, Inc. in its equity and debt investments
- Matrix Industries, Inc. in its equity and debt financing transactions
- Eprazel, Inc. in its strategic financing by Renren, Inc.
- Samumed, LLC in its financing transactions
- SMA Solar Technology AG in its investment in Tigo Energy, Inc.
- Filld, Inc. in its financings by Lightspeed Partners, Javelin Partners and PivotNorth
- Plum, Inc. in its strategic financing by Renren, Inc.
- Procera Networks, Inc. in its acquisition of Vineyard Networks and sale to Francisco Partners
- Viking Therapeutics, Inc. in its IPO, follow-on public offerings and equity line financing
- Kosei, Inc. in its sale to Pinterest, Inc.
- Boomtown Networks, Inc. in its strategic financings
- RightSignature LLC in its sale to Citrix Systems
- Samsung Electronics Co., Ltd. in the sale of its joint venture stake to, and strategic investment in, Corning Incorporated
- Fox Factory in its IPO
- YFind Technologies Private Limited in its sale to Ruckus Wireless, Inc.
- Corsair Components, Inc. in the strategic financing by Francisco Partners and its acquisition of Simple Audio Limited
- The underwriters, led by Goldman, Sachs & Co. and Deutsche Bank Securities, in the initial public offering of Envivio, Inc.
- Monitise plc in its acquisition of ClairMail, Inc.
- Samsung Electronics Co., Ltd. in the sale of its hard disk-drive unit to Seagate Technology
- Exceptional Cloud Services in its sale to Rackspace Hosting, Inc.
- Samsung Electronics, Co., Ltd. in its acquisition of Nexus Dx
- Houlihan Lokey as exclusive dealer-manager for Network Communications, Inc.’s senior notes exchange offer, consent solicitation and balance sheet restructuring
- Hanwha Chemical in its strategic investment in Solarfun Power Holdings
- Mint Software, Inc. (mint.com) in its sale to Intuit, Inc.
- Sybase, Inc. in its 144A-for-life convertible notes offering
- AviaraDx, Inc. in its sale to bioMerieux
- Warburg Pincus in its exchangeable bond investment in Synutra International, Inc.
- CryoCor, Inc. in its IPO
- The Titan Corporation in its acquisition of Jaycor, Inc. in a stock-for-stock merger
- Favrille, Inc. in its IPO
- MannKind Corporation in its IPO
- Applied Micro Circuits Corporation in its acquisition of JNI Corporation
- Woodside Biomedical, Inc. in its sale to Abbott Laboratories
News
- Paul Hastings Advises Organovo Holdings in Sale of FXR Program to Eli Lilly - March 26th, 2025
- Paul Hastings Advises Vantage Discovery in Sale to Shopify - March 21st, 2025
- Paul Hastings Advising Aardvark Therapeutics on Its IPO - February 13th, 2025
- Paul Hastings Advised Xencor, Inc. on $175 Million Common Stock Underwritten Public Offering - September 13th, 2024
- Paul Hastings Advised Semnur Pharmaceuticals, Inc. in $2.5 Billion SPAC Merger Agreement with Denali Capital Acquisition Corp. - September 3rd, 2024
- Paul Hastings Advised Viking Therapeutics on its $632.5 Million Public Offering of Common Stock - March 4th, 2024
- Paul Hastings Advised Zededa, Inc. on $72 Million Growth Financing - February 14th, 2024
- Paul Hastings Advised Kyverna Therapeutics on $319 Million Upsized IPO - February 9th, 2024
- Paul Hastings Advised Jasper Therapeutics on $50 Million Common Stock Offering - February 8th, 2024
- Paul Hastings Advised Corcept Therapeutics in its $145.4 Million Tender Offer - April 7th, 2023
- Paul Hastings Advised Viking Therapeutics in its $287.5 Million Public Offering of Common Stock - April 6th, 2023
- Paul Hastings Advised Jasper Therapeutics in $103.5 Million Public Offering - January 27th, 2023
- Paul Hastings Advised Scilex Holding Company in Business Combination - November 11th, 2022
Insights
- Exchanges Propose Listing Standards Related to Executive Compensation Clawback Rules - April 5th, 2023
- SEC Adopts Amendments Revamping Rule 10b5-1 Trading Regime and Mandating Related Disclosures - December 23rd, 2022
- SEC Adopts Amendments Revamping Rule 10b5-1 Trading Regime and Mandating Related Disclosures - December 23rd, 2022
- SEC Adopts Executive Compensation Clawback Rules - November 4th, 2022
- SEC Adopts Executive Compensation Clawback Rules - November 4th, 2022
Engagement & Publications
- Mentioned in The Daily Journal and Law360 regarding Viking Therapeutics, Inc.'s initial public offering
- Mentioned in The Recorder, The Daily Journal and Law360 regarding representing Kosei, Inc. its its sale to Pinterest, Inc.
- Cheaper, Stronger IPOs Still Elusive After JOBS Act360
- RR Donnelley presents to SEC Hot Topics Institute, San Diego, CA
- Alliance Advisors, Society of Corporate Secretaries & Governance Professionals and Paul Hastings LLP present ISS Proxy Voting Guidelines, Chicago, IL
- Society of Corporate Secretaries and Governance Professionals Presents Hot Issues in Private Company Governance, Colorado Springs, CO
- RR Donnelley presents the SEC Hot Topics Institute, San Diego, CA
- Paul Hastings, Citadel Securities, PricewaterhouseCoopers, MacKenzie Partners and RR Donnelley Present a Briefing on Proxy Access, Executive Compensation and Corporate Governance under the Dodd-Frank (Wall Street Reform) Act:
- Paul Hastings, Houlihan Lokey, BDO Seidman and Thomas Weisel Partners Present a Briefing on Registered Direct and At-the-Market Equity Offerings: Trends for Raising Capital in 2010, Los Angeles, CA
- RR Donnelley presents the SEC Hot Topics Institute, San Diego, CA
- Stafford Publications presents: A Roadmap to Emerging Financing Alternatives Leveraging Opportunities in Rights Offerings, Registered Directs, and More
- Houlihan Lokey, Paul Hastings and Sagient/PlacementTracker Present an Interactive Webinar: PIPEs: The Ever-Evolving Financing Technique
Involvement
- Member of the California State Bar Association
- Member of the Committee on Federal Regulation of Securities of the American Bar Association
- Former member of the Board of Directors of the National Kidney Foundation of Northern California